NIAGEN BIOSCIENCE, INC.: 10-Q filed 2017-08-10

Name: NIAGEN BIOSCIENCE, INC.: 10-Q filed 2017-08-10
Creator: NIAGEN BIOSCIENCE, INC.

What NIAGEN BIOSCIENCE, INC. reported in its quarterly report filed 2017-08-10 (fiscal Q2 2017): 39 published measures, 110 facts as tagged in accession 0001654954-17-007224.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-08-10
Fiscal period: fiscal Q2 2017
Accession: 0001654954-17-007224 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NIAGEN BIOSCIENCE, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-07-01	32,920,164	USD
At 2016-12-31	19,752,068	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-07-01	7,200,741	USD
At 2016-12-31	9,777,710	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2017-07-01	25,719,423	USD
At 2017-04-01	9,372,058	USD
At 2016-12-31	9,974,358	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	-2,764,124	USD	91
2017-01-01 to 2017-07-01	-4,692,879	USD	182
2017-01-01 to 2017-04-01	-1,928,755	USD	91
2016-04-03 to 2016-07-02	-82,667	USD	91
2016-01-03 to 2016-07-02	172,958	USD	182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-01-01 to 2017-07-01	-5,561,880	USD	182
2016-01-03 to 2016-07-02	-2,987,387	USD	182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2017-01-01 to 2017-07-01	295,078	USD	182
2016-01-03 to 2016-07-02	231,201	USD	182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-07-01	18,537,094	USD	182
2016-01-03 to 2016-07-02	1,234,135	USD	182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2017-01-01 to 2017-07-01	-479,036	USD	182
2016-01-03 to 2016-07-02	-426,201	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-07-01	-49,916,453	USD
At 2016-12-31	-45,223,574	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	42,121,150	shares	91
2017-01-01 to 2017-07-01	40,075,920	shares	182
2016-04-03 to 2016-07-02	36,990,032	shares	91
2016-01-03 to 2016-07-02	36,702,037	shares	182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	42,121,150	shares	91
2017-01-01 to 2017-07-01	40,075,920	shares	182
2016-04-03 to 2016-07-02	36,990,032	shares	91
2016-01-03 to 2016-07-02	37,470,066	shares	182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	-0.07	USD/shares	91
2017-01-01 to 2017-07-01	-0.12	USD/shares	182
2016-04-03 to 2016-07-02	0	USD/shares	91
2016-01-03 to 2016-07-02	0	USD/shares	182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	-0.07	USD/shares	91
2017-01-01 to 2017-07-01	-0.12	USD/shares	182
2016-04-03 to 2016-07-02	0	USD/shares	91
2016-01-03 to 2016-07-02	0	USD/shares	182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	0	USD	91
2017-01-01 to 2017-07-01	0	USD	182
2016-04-03 to 2016-07-02	-4,087	USD	91
2016-01-03 to 2016-07-02	6,653	USD	182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-07-01	3,372,879	USD
At 2016-12-31	3,111,374	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	399,861	USD	91
2017-01-01 to 2017-04-01	319,830	USD	91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	-2,718,838	USD	91
2017-01-01 to 2017-07-01	-4,609,683	USD	182
2016-04-03 to 2016-07-02	371,131	USD	91
2016-01-03 to 2016-07-02	825,197	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-07-01	27,376,977	USD
At 2016-12-31	15,736,943	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	45,286	USD	91
2017-01-01 to 2017-07-01	83,196	USD	182
2016-04-03 to 2016-07-02	144,786	USD	91
2016-01-03 to 2016-07-02	332,487	USD	182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-07-01	6,260,018	USD
At 2016-12-31	8,869,150	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-07-01	3,131,759	USD
At 2016-12-31	5,978,288	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2017-07-01	4,579,253	USD
At 2016-12-31	5,852,030	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	4,981,607	USD	91
2017-01-01 to 2017-07-01	8,625,105	USD	182
2016-04-03 to 2016-07-02	3,756,316	USD	91
2016-01-03 to 2016-07-02	6,753,669	USD	182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2017-07-01	7,794,182	USD
At 2016-12-31	7,912,630	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	2,262,769	USD	91
2017-01-01 to 2017-07-01	4,015,422	USD	182
2016-04-03 to 2016-07-02	4,127,447	USD	91
2016-01-03 to 2016-07-02	7,578,866	USD	182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	3,044,086	USD	91
2017-01-01 to 2017-07-01	5,740,555	USD	182
2016-04-03 to 2016-07-02	4,702,132	USD	91
2016-01-03 to 2016-07-02	8,582,658	USD	182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	849,962	USD	91
2017-01-01 to 2017-07-01	1,514,152	USD	182
2016-04-03 to 2016-07-02	751,726	USD	91
2016-01-03 to 2016-07-02	1,215,798	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-07-01	45,571,891	shares
At 2016-12-31	37,544,531	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-07-01	75,590,304	USD
At 2016-12-31	55,160,387	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2017-07-01	1,767,811	USD
At 2016-12-31	486,226	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-07-01	2,111,205	USD
At 2016-12-31	2,170,172	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	-2,764,124	USD	91
2017-01-01 to 2017-07-01	-4,692,879	USD	182
2016-04-03 to 2016-07-02	-86,754	USD	91
2016-01-03 to 2016-07-02	179,611	USD	182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	2,657,573	USD	91
2017-01-01 to 2017-07-01	5,040,719	USD	182
2016-04-03 to 2016-07-02	2,306,559	USD	91
2016-01-03 to 2016-07-02	4,295,118	USD	182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2017-01-01 to 2017-07-01	264,235	USD	182
2016-01-03 to 2016-07-02	159,370	USD	182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2017-01-01 to 2017-07-01	89,803	USD	182
2016-01-03 to 2016-07-02	38,415	USD	182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2017-04-02 to 2017-07-01	-45,286	USD	91
2017-01-01 to 2017-07-01	-83,196	USD	182
2016-04-03 to 2016-07-02	-457,885	USD	91
2016-01-03 to 2016-07-02	-645,586	USD	182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2017-01-01 to 2017-07-01	18,706,284	USD	182
2016-01-03 to 2016-07-02	5,720,000	USD	182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-07-01	179,362	USD	182
2016-01-03 to 2016-07-02	3,628,678	USD	182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-07-01	-2,950,302	USD	182
2016-01-03 to 2016-07-02	-3,892,582	USD	182

Inspect the source

Entity: NIAGEN BIOSCIENCE, INC. / CIK 0001386570
Captured: 2026-09-20T07:59:02.162Z
SEC response SHA-256: 94352bf8b6f04074c9aa98cd63fa97055bc3335ae039584aee12f63320ac36f6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001386570.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))